Clinical Trial Update: Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM) [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the efficacy and safety of GB-0998 for steroid-resistant polymyositis and dermatomyositis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Polymyositis

Drugs mentioned

• GB-0998

Snippet

Sponsor: Japan Blood Products Organization | Conditions: Polymyositis, Dermatomyositis | Phase 3 | Status: COMPLETED